These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19843074)

  • 1. Activity prediction and structural insights of extracellular signal-regulated kinase 2 inhibitors with molecular dynamics simulations.
    Del Rio A; Baldi BF; Rastelli G
    Chem Biol Drug Des; 2009 Dec; 74(6):630-5. PubMed ID: 19843074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of an automated procedure for the prediction of relative free energies of binding on a set of aldose reductase inhibitors.
    Ferrari AM; Degliesposti G; Sgobba M; Rastelli G
    Bioorg Med Chem; 2007 Dec; 15(24):7865-77. PubMed ID: 17870536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational sampling of a cryptic drug binding site in a protein receptor: explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase.
    Frembgen-Kesner T; Elcock AH
    J Mol Biol; 2006 May; 359(1):202-14. PubMed ID: 16616932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a key element for hydrogen-bonding patterns between protein kinases and their inhibitors.
    Katayama N; Orita M; Yamaguchi T; Hisamichi H; Kuromitsu S; Kurihara H; Sakashita H; Matsumoto Y; Fujita S; Niimi T
    Proteins; 2008 Dec; 73(4):795-801. PubMed ID: 18767165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and SAR of squarate inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2).
    Lovering F; Kirincich S; Wang W; Combs K; Resnick L; Sabalski JE; Butera J; Liu J; Parris K; Telliez JB
    Bioorg Med Chem; 2009 May; 17(9):3342-51. PubMed ID: 19364658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can MM-PBSA calculations predict the specificities of protein kinase inhibitors?
    Page CS; Bates PA
    J Comput Chem; 2006 Dec; 27(16):1990-2007. PubMed ID: 17036304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for the high-affinity binding of pyrrolotriazine inhibitors of p38 MAP kinase.
    Sack JS; Kish KF; Pokross M; Xie D; Duke GJ; Tredup JA; Kiefer SE; Newitt JA
    Acta Crystallogr D Biol Crystallogr; 2008 Jul; D64(Pt 7):705-10. PubMed ID: 18566506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding free energies and free energy components from molecular dynamics and Poisson-Boltzmann calculations. Application to amino acid recognition by aspartyl-tRNA synthetase.
    Archontis G; Simonson T; Karplus M
    J Mol Biol; 2001 Feb; 306(2):307-27. PubMed ID: 11237602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular docking/dynamics studies of Aurora A kinase inhibitors.
    Talele TT; McLaughlin ML
    J Mol Graph Model; 2008 Jun; 26(8):1213-22. PubMed ID: 18096419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational proteomics of biomolecular interactions in the sequence and structure space of the tyrosine kinome: deciphering the molecular basis of the kinase inhibitors selectivity.
    Verkhivker GM
    Proteins; 2007 Mar; 66(4):912-29. PubMed ID: 17173284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of binding for a kind of non-peptic HCV NS3 serine protease inhibitors from plants by molecular docking and MM-PBSA method.
    Li X; Zhang W; Qiao X; Xu X
    Bioorg Med Chem; 2007 Jan; 15(1):220-6. PubMed ID: 17064917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational study on the interaction of N1 substituted pyrazole derivatives with B-raf kinase: an unusual water wire hydrogen-bond network and novel interactions at the entrance of the active site.
    Alzate-Morales JH; Vergara-Jaque A; Caballero J
    J Chem Inf Model; 2010 Jun; 50(6):1101-12. PubMed ID: 20524689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A computational model of binding thermodynamics: the design of cyclin-dependent kinase 2 inhibitors.
    Sims PA; Wong CF; McCammon JA
    J Med Chem; 2003 Jul; 46(15):3314-25. PubMed ID: 12852762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding mode.
    Meyers MJ; Pelc M; Kamtekar S; Day J; Poda GI; Hall MK; Michener ML; Reitz BA; Mathis KJ; Pierce BS; Parikh MD; Mischke DA; Long SA; Parlow JJ; Anderson DR; Thorarensen A
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1543-7. PubMed ID: 20137931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
    Hou T; Zhu L; Chen L; Xu X
    J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the molecular mechanics poisson-boltzmann surface area free energy method using a congeneric series of ligands to p38 MAP kinase.
    Pearlman DA
    J Med Chem; 2005 Dec; 48(24):7796-807. PubMed ID: 16302819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular modeling and crystal structure of ERK2-hypothemycin complexes.
    Rastelli G; Rosenfeld R; Reid R; Santi DV
    J Struct Biol; 2008 Oct; 164(1):18-23. PubMed ID: 18571434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing protein kinase selectivity with molecular dynamics and mm-pbsa binding free energy calculations.
    Muzzioli E; Del Rio A; Rastelli G
    Chem Biol Drug Des; 2011 Aug; 78(2):252-9. PubMed ID: 21585710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strong and weak hydrogen bonds in protein-ligand complexes of kinases: a comparative study.
    Panigrahi SK
    Amino Acids; 2008 May; 34(4):617-33. PubMed ID: 18180869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of hydrophobic interactions and hydrogen bond strength by cooperativity: synthesis, modeling, and molecular dynamics simulations of a congeneric series of thrombin inhibitors.
    Muley L; Baum B; Smolinski M; Freindorf M; Heine A; Klebe G; Hangauer DG
    J Med Chem; 2010 Mar; 53(5):2126-35. PubMed ID: 20148533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.